Structural MRI

International Psychogeriatrics

Volumn 23, Issue S2, 2011, Pages S13-S24

  Wattjes, Mike P ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer's disease; dementia; magnetic resonance imaging; neuroimaging

Indexed keywords

AGED; ALZHEIMER DISEASE; ATROPHY; BRAIN; DEMENTIA; HIPPOCAMPUS; HUMAN; METHODOLOGY; MULTIINFARCT DEMENTIA; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PRACTICE GUIDELINE; REVIEW; UTILIZATION REVIEW;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ATROPHY; BRAIN; DEMENTIA; DEMENTIA, VASCULAR; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; NEUROIMAGING; PRACTICE GUIDELINES AS TOPIC;

EID: 84856507736     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610211000913     Document Type: Review

References (50)

1. Bastos-Leite A. J., van Straaten E. C., Scheltens P., Lycklama G. and Barkhof F. (2004). Thalamic lesions in vascular dementia: low sensitivity of fluid-attenuated inversion recovery (FLAIR) imaging. Stroke, 35, 415–419.
2. Bouwman F. H., et al(2007). CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairment. Neurobiology of Aging, 28, 1070–1074.
3. Boxer A. L., et al(2006). Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy. Archives of Neurology, 63, 81–86.
4. Braak H. and Braak E. (1991). Neuropathological staging of Alzheimer-related changes. Acta Neuropathology, 82, 239–259.
5. Chabriat H., et al(1998). Patterns of MRI lesions in CADASIL. Neurology, 51, 452–457.
6. Cordonnier C. and van der Flier W. M. (2011) Brain microbleeds and Alzheimer's disease: innocent observation or key player? Brain, 134, 335–344.
7. Cordonnier C., van der Flier W. M., Sluimer J. D., Leys D., Barkhof F. and Scheltens F. (2006). Prevalence and severity of microbleeds in a memory clinic setting. Neurology, 66, 1356–1360.
8. Davatzikos C., Bhatt P., Shaw L. M., Batmanghelich K. N. and Trojanowski J. Q. (2010). Prediction of MCI to AD via MRI, CSF biomarkers, and pattern classification. Neurobiology of Aging. Epublished ahead of print.
9. DeCarli C. S. (2006). When two are worse than one: stroke and Alzheimer's disease. Neurology, 67, 1326–1327.
10. de la Torre J. C. (2004). Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialects. Lancet Neurology, 3, 184–190.
11. Dubois B., et al(2007). Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRA criteria. Lancet Neurology, 6, 734–746.
12. Fazekas F., et al(1987). MR signal abnormalities at 1.5T in Alzheimer's disease and normal ageing. AJR American Journal of Roentgenology, 149, 351–356.
13. Frisoni G. B., et al(2007). The topography of grey matter involvement in early and late onset Alzheimer's disease. Brain, 130, 720–730.
14. Frisoni G. B., Fox N. C., Jack C. R. Jr, Scheltens P. and Thompson P. M. (2010). The clinical use of structural MRI in Alzheimers disease. Nature Review of Neurology, 6, 67–77.
15. Goos J. D., et al(2009). Patients with Alzheimer disease with multiple microbleeds: relation with cerebrospinal fluid biomarkers and cognition. Stroke, 40, 3455–3460.
16. Goos J. D., et al(2010). Incidence of cerebral microbleeds: a longitudinal study in a memory clinic population. Neurology, 74, 1954–1960.
17. Gorno-Tempini M. L., et al(2011). Classification of primary progressive aphasia and its variants. Neurology, 76, 1006–1014.
18. Guermazi A., et al(2007). Neuroradiological findings in vascular dementia. Neuroradiology, 49, 1–22.
19. Hort J., et al(2010). EFNS guidelines for the diagnosis and management of Alzheimer's disease. European Journal of Neurology, 17, 1236–1348.
20. Inzitari D., et al(2009). Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukariosis and disability) study cohort. BMJ, 339, 2477.
21. Jack C. R. Jr., et al(1998). Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease. Neurology, 51, 993–999.
22. Jones B. F., et al(2006). Differential regional atrophy of the cingulate gyrus in Alzheimer disease: a volumetric MRI study. Cerebral Cortex, 16, 1701–1708.
23. Johnston S. C., et al(2004). Cognitive impairment and decline are associated with carotid artery disease in patients without clinically evident cerbrovascular disease. Annals of Internal Medicine, 140, 237–247.
24. Kalaria R. N. and Ballard C. (1999). Overlap between pathology of Alzheimer's disease and vascular dementia. Alzheimer Disease and Associated Disorders, 13 (Suppl. 3), S115–S123.
25. Karas G., et al(2007). Precuneus atrophy in early-onset Alzheimer's disease: a morphometric structural MRI study. Neuroradiology, 49, 967–976.
26. Kirsch W., et al(2009). Serial susceptibility weighted MRI measures brain iron and microbleeds in dementia. Journal of Alzheimer's Disease, 17, 599–609.
27. Likeman M., et al(2005). Visual assessment of atrophy on magnetic resonance imaging in the diagnosis of pathologically confirmed young-onset dementias. Archives of Neurology, 62, 1410–1415.
28. Linn J., et al(2010). Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. Neurology, 74, 1346–1350.
29. McKhann G., Drachman D., Folstein M., Katzman R., Price D. and Stadlan E. M. (1984). Clinical diagnosis of Alzheimer's disease: a report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34, 939–944.
30. Neary D., et al(1998). Fronto-temporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology, 51, 1546–1554.
31. Oba H., et al(2005). New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology, 64, 2050–2055.
32. Pasquier F., et al(1996) Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scan with hemispheric infarcts. European Neurology, 36, 268–272.
33. Poels M. M., et al(2011). Incidence of cerebral microbleeds in the general population: the Rotterdam Scan Study. Stroke 42, 656–661.
34. Pohjasvaara T., Mätyla R., Ylikoski R., Kaste M. and Erkinjunti T. (2000). Comparison of different clinical criteria (DSM-III, ADDTC, ICD-10, NINDS-AIREN, DSM-IV) for the diagnosis of vascular dementia. National Institute of Neurological disorders and Stroke-Association Internationale pour la recherché at l'enseignement en neurosciences. Stroke, 31, 2952–2957.
35. Riidha B. H., et al(2006). Tracking atrophy in familial Alzheimer's disease: a serial MRI study. Lancet Neurology, 5, 828–834.
36. Román C.G., et al(1993). Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN international workshop. Neurology, 43, 250–260.
37. Rosen H. J., et al(2002). Patterns of brain atrophy in frontotemporal dementia and semantic dementia. Neurology, 58, 198–208.
38. Scheltens P., et al(1992). Atrophy of the medial temporal lobe on MRI in probable Alzheimer's disease and normal ageing brain: diagnostic value and neuropsychological correlates. Journal of Neurology Neurosurgery and Psychiatry, 55, 967–972.
39. Scheltens P., et al(1998). White matter changes on CT and MRI: an overview of visual rating scales. Eur Neurol, 39, 80–89.
40. Scheltens P., Fox N., Barkhof F. and De Carli C. (2002). Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion. Lancet Neurology, 1, 13–21.
41. Shiga Y., et al(2004). Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jacob disease. Neurology, 63, 443–449.
42. Shiino A., et al(2008). Different atrophic patterns in early- and late-onset Alzheimer's disease and evaluation of clinical utility of a method of regional z-score analysis using voxel-based morphometry. Dementia and Geriatric Cognitive Disorders, 26, 175–186.
43. Tschampa H. J., Zerr I. and Urbach H. (2007). Radiological assessment of Creutzfeldt-Jacob disease. European Radiology, 17, 1200–1211.
44. Tzourio C., et al(2003). Effects of blood pressure lowering with perindipril and indamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Archives of Internal Medicine, 163, 1069–1075.
45. van Straaten E. C. W., Scheltens P. and Barkhof F. (2004). MRI and CT in the diagnosis of vascular dementia. Journal of Neurology Science, 226, 9–12.
46. Vernooij M. W., Ikram M. A., Hofman A., Krestin G. P., Breteler M. M. and van der Lugt A. (2009). Superficial siderosis in the general population. Neurology, 73, 202–205.
47. Vitali P., et al(2008). Neuroimaging in dementia. Seminars in Neurology, 28, 467–483.
48. Warmuth-Metz M., et al(2001). Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy. Archives of Neurology, 58, 1076–1079.
49. Wattjes M. P., et al(2009). Diagnostic imaging of patients in a memory clinic: comparison of MR imaging and 64-detector row CT. Radiology, 253, 174–183.
50. Zeidler M., et al(2000). The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jacob disease. Lancet, 355, 1412–1418.